Bevacizumab therapy for macular edema in central retinal vein occlusion: Long-term results
Open Access
- 1 January 2009
- journal article
- research article
- Published by Medknow in Oman Journal of Ophthalmology
- Vol. 2 (2) , 73-8
Abstract
Background: There is no proven effective treatment for vision loss in central retinal vein occlusion (CRVO). Bevacizumab has been reported in small series with limited follow-up, to have a positive effect in reducing cystoid macular edema (CME) and improving vision in CRVO. Purpose: To report long-term results with the use of bevacizumab in CRVO. Materials and Methods: Prospective interventional case series included 15 patients, serially evaluated with best corrected visual acuity (BCVA), optical coherence tomography (OCT), fluorescein angiography, and tonometry. Results were statistically analyzed. Results: Mean follow-up was 12 ? 3.6 months (range, 6−18 months); mean number of injections was 2.2 (range, 1−4) per patient. Statistically significant reduction of macular thickness (P < 0.001) was seen at six weeks (mean, 346 ?); three months (mean, 353 ?); six months (mean, 348 ?); and final follow-up (mean, 342 ?). Significant BCVA improvement was seen at six weeks (mean, 0.27 logMAR), three months (mean, 0.3 logMAR), three months (0.15 logMAR), and final follow-up (mean, 0.21 logMAR) (P = 0.009). Also, 73.3% patients had BCVA improvement at the last follow-up. Conclusion: Intravitreal bevacizumab is an effective treatment option for CME in CRVO patients. Reinjections at appropriate timing, based on the OCT findings, are important for better visual outcome.Keywords
This publication has 23 references indexed in Scilit:
- Bevacizumab in retinal vein occlusion-results of a prospective case seriesGraefe's Archive for Clinical and Experimental Ophthalmology, 2007
- Bevacizumab zur Therapie des sekundären Makulaödems nach venösen GefäßverschlüssenDer Ophthalmologe, 2006
- Intravitreal Triamcinolone for the Treatment of Macular Edema AssociatedWith Central Retinal Vein OcclusionArchives of Ophthalmology (1950), 2004
- Intravitreal triamcinolone acetonide for macular oedema due to central retinal vein occlusionBritish Journal of Ophthalmology, 2002
- Morphologie des lésions rétinennes précoces après occlusion veineuse expérimentale*Klinische Monatsblätter für Augenheilkunde, 1996
- Evaluation of Grid Pattern Photocoagulation for Macular Edema in Central Vein OcclusionOphthalmology, 1995
- Vascular Endothelial Growth Factor in Ocular Fluid of Patients with Diabetic Retinopathy and Other Retinal DisordersNew England Journal of Medicine, 1994
- Hemodilution therapy in central retinal vein occlusionGraefe's Archive for Clinical and Experimental Ophthalmology, 1994
- A randomised prospective study of treatment of non-ischaemic central retinal vein occlusion by isovolaemic haemodilution.British Journal of Ophthalmology, 1989
- Central retinal vein occlusion: a prospective histopathologic study of 29 eyes in 28 cases.1981